Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE | Positron-Emission Tomography | Recruiting | Not applicable | 2026-07-21 | NCT05188872 | |
| Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Early phase 1 | 2026-07-21 | NCT04504526 | |
| Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies | Patients With Advanced Metastatic FAP-Positive Tumors | Active, not recruiting | Phase 1 | 2026-07-02 | NCT07681141 | |
| Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-05-01 | NCT07562438 | |
| Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-29 | NCT07117760 | |
| Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-23 | NCT07363486 | |
| The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-23 | NCT07363382 | |
| 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 / Phase 3 | 2025-10-07 | NCT07209878 | |
| 18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study | cancer, neoplasm | Recruiting | Early phase 1 | 2024-12-16 | NCT06734572 | |
| 68Ga-NI-FAPI PET/CT: First-in-human Study | cancer, neoplasm | Recruiting | Early phase 1 | 2024-11-14 | NCT06688305 | |
| 68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study | cancer, neoplasm | Recruiting | Early phase 1 | 2024-11-14 | NCT06688188 | |
| 68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies | cancer, neoplasm | Recruiting | Early phase 1 | 2024-11-14 | NCT06438250 |